483 filings
Page 4 of 25
8-K/A
htf75a4gyv
24 Mar 16
Entry into a Material Definitive Agreement
12:00am
8-K
mz3ybvj 02
9 Mar 16
Alexza Pharmaceuticals Receives Positive
12:00am
8-K
nfze62 yhc68
29 Feb 16
Other Events
12:00am
8-K
8b03sacm7 naq7mbzx7
24 Feb 16
Entry into a Material Definitive Agreement
12:00am
D
2wair1 rw1ecrr
24 Feb 16
$5M in equity, sold $5M, 1 investor
12:00am
8-K
wethp
22 Jan 16
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
3svubics66 xn
22 Dec 15
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
c3yuf766a ikaucjm
21 Dec 15
Alexza Pharmaceuticals Announces Interim Results from its
12:00am
424B3
jkkss
17 Nov 15
Prospectus supplement
12:00am
CT ORDER
wn1midogx
16 Nov 15
Confidential treatment order
12:00am
8-K
v9nd7
5 Nov 15
Alexza Reports 2015 Third Quarter Financial Results
12:00am
8-K
c6j6x fb3ma499
30 Oct 15
Departure of Directors or Certain Officers
12:00am
8-K
7ylxouyq7 d49ndi00vh
30 Oct 15
Alexza Pharmaceuticals Announces Intent to Reacquire U.S. Rights
12:00am
S-8
sxs9pi99mez
23 Oct 15
Registration of securities for employees
12:00am
8-K
g9kj41jewahp zjpu
14 Oct 15
Other Events
12:00am
8-K
9r0 ugtz3f1fon
13 Oct 15
Departure of Directors or Certain Officers
12:00am
8-K
c0gasmp24bslr qzn
2 Oct 15
Alexza Pharmaceuticals Announces Management Promotions
12:00am
D
iex4cb seze
28 Sep 15
$143.75K in equity, sold $143.75K, 1 investor
12:00am
8-K
yp50tq5cl440jir
28 Sep 15
Alexza Retains Guggenheim Securities, LLC to Explore Strategic Options
12:00am